Article Details
Retrieved on: 2021-08-02 16:07:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Messenger RNA (mRNA)-focused Moderna has the rights to use Autolus' proprietary binders for four immunology targets. London-based Autolus ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here